Bicycle raises £20m series A from prime investor syndicate

Bicycle Therapeutics of the UK has raised £20m in a series A financing round for the clinical development of its therapeutic bicycle drug candidates in oncology.

Bicycle Therapeutics of the UK has raised £20m in a series A financing round for the clinical development of its therapeutic bicycle drug candidates in oncology.

The existing investor syndicate comprising Atlas Venture, Novartis Venture Fund, SR One, SV Life Sciences and Astellas Venture Management participated...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip